{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:46:32Z","timestamp":1788306392571,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00431-016-2700-3","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T18:26:29Z","timestamp":1455906389000},"page":"445-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["\u201cNihilism\u201d of chronic heart failure therapy in children and why effective therapy is withheld"],"prefix":"10.1007","volume":"175","author":[{"given":"Dietmar","family":"Schranz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert F.","family":"Voelkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"crossref","unstructured":"(1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The aldosterone CONSENSUS Trial Study Group. N Engl J Med 316:1429\u20131435","DOI":"10.1056\/NEJM198706043162301"},{"key":"2700_CR2","doi-asserted-by":"crossref","unstructured":"(1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001\u20132007","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"2700_CR3","doi-asserted-by":"crossref","unstructured":"(1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 353: 9\u201313","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"2700_CR4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.0000139844.15045.F9","volume":"110","author":"I Ahmet","year":"2004","unstructured":"Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI (2004) Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110:1083\u20131090","journal-title":"Circulation"},{"key":"2700_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/jpet.107.135335","volume":"325","author":"I Ahmet","year":"2008","unstructured":"Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, Xiao RP, Lakatta EG, Talan MI (2008) Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction. J Pharmacol Exp Ther 325:491\u2013499","journal-title":"J Pharmacol Exp Ther"},{"key":"2700_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1542\/peds.101.3.369","volume":"101","author":"A Arola","year":"1998","unstructured":"Arola A, Tuominen J, Ruuskanen O, Jokinen E (1998) Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics 101:369\u2013376","journal-title":"Pediatrics"},{"key":"2700_CR7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98\u2013102","journal-title":"Science"},{"issue":"1","key":"2700_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2010.11.007","volume":"31","author":"D Bernstein","year":"2011","unstructured":"Bernstein D, Fajardo G, Zhao M (2011) The role of \u00df-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection. Prog Pediatr Cardiol 31(1):35\u201338","journal-title":"Prog Pediatr Cardiol"},{"key":"2700_CR9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/ATVBAHA.112.251769","volume":"32","author":"S Bhushan","year":"2012","unstructured":"Bhushan S, Kondo K, Predmore BL, Zlatopolsky M, King AL, Pearce C, Huang H, Tao YX, Condit ME, Lefer DJ (2012) Selective beta2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 32:1865\u20131874","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2700_CR10","first-page":"R1197","volume":"272","author":"ML Blair","year":"1997","unstructured":"Blair ML, Woolf PD, Felten SY (1997) Sympathetic activation cannot fully account for increased plasma renin levels during water deprivation. Am J Physiol 272:R1197\u2013R1203","journal-title":"Am J Physiol"},{"key":"2700_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0031-6997(25)06662-1","volume":"43","author":"O-E Brodde","year":"1991","unstructured":"Brodde O-E (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203\u2013242","journal-title":"Pharmacol Rev"},{"key":"2700_CR12","doi-asserted-by":"crossref","unstructured":"Buchhorn R, Ross RD, Bartmus D, Wessel A, Hulpke-Wette M, B\u00fcrsch J (2001) Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. Int J Cardiol 78(3):225\u2013230, discussion 230\u20131","DOI":"10.1016\/S0167-5273(01)00398-9"},{"issue":"2\u20133","key":"2700_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-5273(01)00413-2","volume":"79","author":"R Buchhorn","year":"2001","unstructured":"Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, B\u00fcrsch J (2001) Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. Int J Cardiol 79(2\u20133):167\u2013173","journal-title":"Int J Cardiol"},{"key":"2700_CR14","first-page":"525","volume":"306","author":"Digitalis Investigation Group (DIG)","year":"1997","unstructured":"Digitalis Investigation Group (DIG) (1997) The effect of digoxin in mortality and morbidity in patients with heart failure. N Engl J Med 306:525\u2013533","journal-title":"N Engl J Med"},{"key":"2700_CR15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00246-013-0683-7","volume":"34","author":"O Elkiran","year":"2013","unstructured":"Elkiran O, Sandikkaya A, Kocak G, Karakurt C, Taskapan C, Yologlu S (2013) Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and Ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts. Pediatr Cardiol 34:1583\u20131589","journal-title":"Pediatr Cardiol"},{"key":"2700_CR16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.62.5.811","volume":"62","author":"MA Engle","year":"1978","unstructured":"Engle MA, Lewy JE, Lewy, Metcoff J (1978) The use of furosemide in the treatment of edema in infants and children. Pediatrics 62:811\u2013818","journal-title":"Pediatrics"},{"key":"2700_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.yjmcc.2011.06.019","volume":"51","author":"G Fajardo","year":"2011","unstructured":"Fajardo G, Zhao M, Berry G, Wong LJ, Mochly-Rosen D, Bernstein D (2011) Beta2-Adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways. J Mol Cell Cardiol 51:781\u2013789","journal-title":"J Mol Cell Cardiol"},{"key":"2700_CR18","doi-asserted-by":"crossref","unstructured":"Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ (2012) Diuretics for heart failure. Cochrane Database Syst Rev CD003838","DOI":"10.1002\/14651858.CD003838.pub3"},{"key":"2700_CR19","first-page":"2690","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C (2003) Clinical investigation and reports vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure. Results from a double-blind. Randomized Trial Circ 107:2690\u20132696","journal-title":"Randomized Trial Circ"},{"issue":"1","key":"2700_CR20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/ped.12590","volume":"57","author":"D Hirano","year":"2015","unstructured":"Hirano D, Kakegawa D, Yamada A, Ito A, Miwa S, Ida H (2015) Tolvaptan in a pediatric patient with diuretic-resistant heart and kidney failure. Pediatr Int 57(1):183\u2013185","journal-title":"Pediatr Int"},{"key":"2700_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCHEARTFAILURE.108.820217","volume":"2","author":"DT Hsu","year":"2009","unstructured":"Hsu DT, Pearson GD (2009) Heart failure in children. Part I: history, etiology, and pathophysiology. Circ Heart Fail 2:63\u201370","journal-title":"Circ Heart Fail"},{"key":"2700_CR22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/CIRCHEARTFAILURE.109.856229","volume":"2","author":"DT Hsu","year":"2009","unstructured":"Hsu DT, Pearson GD (2009) Part II: diagnosis, treatment, and future directions. Circ Heart Fail 2:490\u2013498","journal-title":"Circ Heart Fail"},{"key":"2700_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.109.927988","volume":"122","author":"DT Hsu","year":"2010","unstructured":"Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, Barker PC, Ravishankar C, McCrindle BW, Williams RV, Altmann K, Ghanayem NS, Margossian R, Chung WK, Border WL, Pearson GD, Stylianou MP, Mital S (2010) Enalapril in infants with single ventricle. Results of a multicenter randomized trial. Circulation 122:333\u2013340","journal-title":"Circulation"},{"key":"2700_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0974-2069.58317","volume":"2","author":"S Jain","year":"2009","unstructured":"Jain S, Vaidyanathan B (2009) Digoxin in management of heart failure in children: should it be continued or relegated to the history books? Ann Pediatr Cardiol 2:149\u2013152","journal-title":"Ann Pediatr Cardiol"},{"key":"2700_CR25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","volume":"29","author":"PF Kantor","year":"2013","unstructured":"Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, Dillenburg R, Atallah J, Buchholz H, Chant-Gambacort C, Conway J, Gardin L, George K, Greenway S, Human DG, Jeewa A, Price JF, Ross RD, Roche SL, Ryerson L, Soni R, Wilson J, Wong K et al (2013) Presentation, diagnosis, and medical management of heart failure in children: Canadian cardiovascular society guidelines. Can J Cardiol 29:1535\u20131552","journal-title":"Can J Cardiol"},{"issue":"4","key":"2700_CR26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrcardio.2015.6","volume":"12","author":"H Latus","year":"2015","unstructured":"Latus H, Schranz D, Apitz C (2015) Treatment of pulmonary arterial hypertension in children. Nat Rev Cardiol 12(4):244\u2013254","journal-title":"Nat Rev Cardiol"},{"key":"2700_CR27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","volume":"348","author":"SE Lipshultz","year":"2003","unstructured":"Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647\u20131655","journal-title":"N Engl J Med"},{"key":"2700_CR28","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1253\/circj.CJ-12-1271","volume":"77","author":"S Masutani","year":"2013","unstructured":"Masutani S, Saiki H, Kurishima C, Ishido H, Tamura M, Senzaki H (2013) Heart failure with preserved ejection fraction in children. Hormonal imbalance between aldosterone and brain natriuretic peptide. Circ J 77:2375\u20132382","journal-title":"Circ J"},{"key":"2700_CR29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray JJV, Adamopoulos S, Anker SD Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K\u00f8ber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R\u00f8nnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 33:1787\u20131847","journal-title":"Eur Heart J"},{"key":"2700_CR30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR (2014) Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"2700_CR31","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/0006-2952(85)90371-5","volume":"34","author":"M Milavec-Krizman","year":"1985","unstructured":"Milavec-Krizman M, Evenou JP, Wagner H, Berthold R, Stoll AP (1985) Characterization of beta-adrenoceptor subtypes in rat kidney with new highly selective beta 1 blockers and their role in renin release. Biochem Pharmacol 34:3951\u20133957","journal-title":"Biochem Pharmacol"},{"key":"2700_CR32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.CIR.95.6.1568","volume":"95","author":"Z Ming","year":"1997","unstructured":"Ming Z, Parent R, Lavall\u00e9e M (1997) \u03b22-Adrenergic dilation of resistance coronary vessels involves KATP channels and nitric oxide in conscious dogs. Circulation 95:1568\u20131576","journal-title":"Circulation"},{"key":"2700_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/ehs229","volume":"35","author":"SD Miyamoto","year":"2014","unstructured":"Miyamoto SD, Stauffer BL, Nakano S, Sobus R, Nunley K, Nelson P, Sucharov CC (2014) Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 35:33\u201341","journal-title":"Eur Heart J"},{"issue":"8","key":"2700_CR34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2014.02.030","volume":"33","author":"SD Miyamoto","year":"2014","unstructured":"Miyamoto SD, Stauffer BL, Polk J, Medway A, Friedrich M, Haubold K, Peterson V, Nunley K, Nelson P, Sobus R, Stenmark KR, Sucharov CC (2014) Gene expression and \u03b2-adrenergic signaling are altered in hypoplastic left heart syndrome. J Heart Lung Transplant 33(8):785\u2013793","journal-title":"J Heart Lung Transplant"},{"key":"2700_CR35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.113.001383","volume":"129","author":"KS Motonaga","year":"2014","unstructured":"Motonaga KS, Dubin AM (2014) Cardiac resynchronization therapy for pediatric patients with heart failure and congenital heart disease: a reappraisal of results. Circulation 129:1879\u20131891","journal-title":"Circulation"},{"key":"2700_CR36","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despr\u00e9s JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics 2015 update: a report from the American Heart Association. Circulation 131:e29\u2013e322","journal-title":"Circulation"},{"issue":"5","key":"2700_CR37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00246-012-0373-x","volume":"34","author":"T Murakami","year":"2013","unstructured":"Murakami T, Horibata Y, Morimoto Y, Tateno S, Kawasoe Y, Niwa K (2013) Syndrome of inappropriate secretion of antidiuretic hormone associated with angiotensin-converting enzyme inhibitor administration. Pediatr Cardiol 34(5):1261\u20131263","journal-title":"Pediatr Cardiol"},{"key":"2700_CR38","doi-asserted-by":"crossref","unstructured":"Navaratnarajah M, Siedlecka U, Ibrahim M, van Doorn C, Soppa G, Gandhi A, Shah A, Kukadia P, Yacoub MH, Terracciano CM (2014) Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading. PLoS One 9(9). Published online Sep 30, 2014","DOI":"10.1371\/journal.pone.0092909"},{"key":"2700_CR39","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","volume":"348","author":"AW Nugent","year":"2003","unstructured":"Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG (2003) The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348:1639\u20131646","journal-title":"N Engl J Med"},{"key":"2700_CR40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651\u20131658","journal-title":"N Engl J Med"},{"key":"2700_CR41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"2700_CR42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","volume":"289","author":"SS Rathore","year":"2003","unstructured":"Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289:871\u2013878","journal-title":"JAMA"},{"key":"2700_CR43","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.healun.2013.07.005","volume":"32","author":"S Recla","year":"2013","unstructured":"Recla S, Steinbrenner B, Schranz D (2013) Medical therapy in dilated cardiomyopathy and pulmonary arterial banding in children. J Heart Lung Transplant 32:1045\u20131046","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"2700_CR44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00246-013-0671-y","volume":"34","author":"RB Regen","year":"2013","unstructured":"Regen RB, Gonzalez A, Zawodniak K, Leonard D, Quigley R, Barnes AP, Koch JD (2013) Tolvaptan increases serum sodium in pediatric patients with heart failure. Pediatr Cardiol 34(6):1463\u20131468","journal-title":"Pediatr Cardiol"},{"key":"2700_CR45","unstructured":"Rinaldi B, Donniacuo M, Sodano L. Effects of the new ultra-long-acting \u03b22-AR agonist indacaterol in chronic treatment alone or in combination with the \u03b21-AR blocker metoprolol on cardiac remodeling. Br J Pharmacol in press"},{"key":"2700_CR46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0025-6196(12)60063-9","volume":"68","author":"RJ Rodeheffer","year":"1993","unstructured":"Rodeheffer RJ, Jacobsen SJ, Gersh BJ, Kottke TE, McCann HA, Bailey KR, Ballard DJ (1993) The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 68:1143\u20131150","journal-title":"Mayo Clin Proc"},{"key":"2700_CR47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9149(87)91118-0","volume":"59","author":"RD Ross","year":"1987","unstructured":"Ross RD, Daniels SR, Schwartz DC, Hannon DW, Shukla R, Kaplan S (1987) Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 59:911\u2013914","journal-title":"Am J Cardiol"},{"key":"2700_CR48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/CIRCULATIONAHA.113.003615","volume":"129","author":"MD Rossano JW","year":"2014","unstructured":"Rossano JW MD, Shaddy RE (2014) Update on pharmacological heart failure therapies in children. Do adult medications work in children and if not, why not? Circulation 129:607\u2013612","journal-title":"Circulation"},{"key":"2700_CR49","unstructured":"Rossano JW. Medical therapy of pediatric heart failure: what have we learned in the last 10 years? | Expert Analysis. JACC; Apr 07, 2015, see more at: http:\/\/www.acc.org\/latest-in-cardiology\/articles\/2015\/04\/06\/11\/41\/medical-therapy-of-pediatric-heart-failure ?"},{"key":"2700_CR50","first-page":"1","volume":"12","author":"S Rupp","year":"2014","unstructured":"Rupp S, Apitz C, Tholen L, Latus H, Ostermayer SH, Schmidt D, Bauer J, Schranz D et al (2014) Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers. Cardiol Young 12:1\u20136","journal-title":"Cardiol Young"},{"key":"2700_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1389974","volume":"227","author":"AA Schmaltz","year":"2015","unstructured":"Schmaltz AA (2015) Chronic congestive heart failure in infancy and childhood. New aspects of diagnosis and treatment. Klin Padiatr 227:3\u20139","journal-title":"Klin Padiatr"},{"key":"2700_CR52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.87.2.422","volume":"87","author":"D Schranz","year":"1993","unstructured":"Schranz D, Droege A, Broede A, Brodermann G, Schafer E, Oelert H, Brodde OE (1993) Uncoupling of human cardiac adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest. Circulation 87:422\u2013426","journal-title":"Circulation"},{"key":"2700_CR53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.healun.2013.01.988","volume":"32","author":"D Schranz","year":"2013","unstructured":"Schranz D, Rupp S, M\u00fcller M, Schmidt D, Bauer A, Valeske K, Michel-Behnke I, Jux C, Apitz C, Thul J, Hsu D, Akint\u00fcrk H (2013) Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: a novel therapeutic strategy before heart transplantation. J Heart Lung Transplant 32:475\u2013481","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"2700_CR54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00246-014-1015-2","volume":"36","author":"D Schranz","year":"2015","unstructured":"Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D, Apitz C, Thul J, Valeske K, Bauer J, M\u00fcller M, Jux C, Michel-Behnke I, Akint\u00fcrk H (2015) Fifteen-year single center experience with the \u201cGiessen Hybrid\u201d approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol 36(2):365\u2013373","journal-title":"Pediatr Cardiol"},{"key":"2700_CR55","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0002-9149(99)00109-5","volume":"83","author":"M Seguchi","year":"1999","unstructured":"Seguchi M, Nakazawa M, Momma K (1999) Further evidence suggesting a limited role of digitalis in infants with circulatory congestion secondary to large ventricular septal defect. Am J Cardiol 83:1408\u20131411","journal-title":"Am J Cardiol"},{"key":"2700_CR56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY (2007) Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298:1171\u20131179","journal-title":"JAMA"},{"issue":"12","key":"2700_CR57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/clc.4960281203","volume":"28","author":"AD Shah","year":"2005","unstructured":"Shah AD, Arora RR (2005) Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors? Clin Cardiol 28(12):551\u2013555","journal-title":"Clin Cardiol"},{"issue":"9208","key":"2700_CR58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(00)99016-0","volume":"355","author":"T Thum","year":"2000","unstructured":"Thum T, Borlak J (2000) Gene expression in distinct regions of the heart. Lancet 355(9208):979\u2013983","journal-title":"Lancet"},{"issue":"7","key":"2700_CR59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5414\/CN108457","volume":"84","author":"N Tominaga","year":"2015","unstructured":"Tominaga N, Kida K, Matsumoto N, Akashi YJ, Miyake F, Kimura K, Shibagaki Y (2015) Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics\/pharmacodynamics study. Clin Nephrol 84(7):29\u201338","journal-title":"Clin Nephrol"},{"key":"2700_CR60","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","volume":"296","author":"JA Towbin","year":"2006","unstructured":"Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867\u20131876","journal-title":"JAMA"},{"key":"2700_CR61","doi-asserted-by":"crossref","unstructured":"Voelkel N, Schranz D (2015) The right ventricle in health and disease. Springer","DOI":"10.1007\/978-1-4939-1065-6"},{"key":"2700_CR62","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1681\/ASN.2005121334","volume":"17","author":"M Volpe","year":"2006","unstructured":"Volpe M, Tocci G, Pagannone E (2006) Fewer mega-trials and more clinically oriented studies in hypertension research? The case of blocking the renin- angiotensin-aldosterone system. J Am Soc Nephrol 17:S36\u2013S43","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2700_CR63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tips.2004.05.007","volume":"25","author":"RP Xiao","year":"2004","unstructured":"Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H (2004) Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25(7):358\u2013365","journal-title":"Trends Pharmacol Sci"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-016-2700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-016-2700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-016-2700-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T08:59:17Z","timestamp":1748768357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-016-2700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s00431-016-2700-3","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]}}}